EnTrust™ Single Chamber ICD
Patient-Centered Therapy
that promotes natural cardiac function1

EnTrust
Model D154VRC
EnTrust D154VRC1
35J delivered
8 seconds BOL, 11.8 seconds ERI
10.7 years*
35cc, 68g
Programmable Active Can®
* 10.7 years — Conditions: 15% VVI at 60 ppm,
3 V, 0.4 ms, 500 ohms; pre-arrhythmia EGM storage off; biannual charges
11 years — Conditions: 15% VVI at 60 ppm, 2.5 V, 0.4 ms, 900 ohms;
pre-arrhythmia EGM storage off; biannual charges
Unique features to reduce appropriate and inappropriate shocks
ATP During Charging to reduce appropriate shocks2,
3
- Reduce 3 out of 4 shocks2, 3 with
proven PainFREE programming, with no delay to definitive therapy.1
- Exclusive Advancement -- Nominally ON1
ATP
During Charging automatically delivers ATP while the capacitor
charges, offering PainFREE termination of Fast VTs in the VF Zone with No
Delay to definitive therapy.1
Medtronic
PainFREE RX II clinical conclusion: "compared to shocks, empirical
ATP for FVT is highly effective, equally safe, and improves patient
quality of life. It prevents painful shocks without any clinical difference
in episode duration, arrhythmic syncope, acceleration, or sudden death."3
Request
information on Medtronic PainFREE Therapy Clinical Results and
Programming Tips.
Accurate Detection to reduce inappropriate shocks2
Wavelet™ Dynamic Discrimination
Wavelet is an electrogram morphology algorithm
with simple on-off programming. It automatically compares the electrogram
(EGM) morphology during high rate rhythms to a stored template of normal
(baseline) rhythm.1
Accurate detection, therapy when needed
Wavelet delivers fewer inappropriate therapies for SVT (compared
to EGM width)6 and has been shown to increase
specificity without decreasing sensitivity.7
Robust,
ongoing template quality monitoring 6, 7
Wavelet adapts
to changes in electrogram morphology and updates it automatically to
adapt to changes in the morphology of normal beats.1
Clinically Proven Shock Reduction
112 centers, 1122 patients, 2237 episodes4
- Clinically proven in the largest worldwide single chamber discrimination study.
- Substantially reduced inappropriate therapy 78.2%**
- Maintained 99.2% sensitivity based on 100% spontaneous arrhythmias.
Complete Information for More Efficient
Patient Care1, 5,
| EXCLUSIVE |
Cardiac
Compass® Trends provides 14 months of trended
data to aid device and drug therapy management and manage disease
progression. |
| EXCLUSIVE |
Histograms include
information prior to and since last session for easy comparison. |
| NEW |
Detailed, easy-to-use, clinically oriented Episode Logs. |
| NEW |
Summary
Parameter Screen saves time and reduces programming
steps4 |
Total AT/AF Co-morbidity Management
EnTrust family of ICDs provides a suite of features for total AT/AF
co-morbidity management, including diagnostics to detect when your patient
develops AT/AF, and both termination and intervention therapies.
- Reactive
ATP offers more opportunities to terminate long AT
episodes.
- Patient activated cardioversion with the InCheck Patient
Assistant
- Cardiac Compass® Trends provides unique
AF burden trending as well as V. rate during AT/AF
(bpm)
- Atrial Preference Pacing (APP)
- Atrial Rate Stabilization (ARS)
- Post-Mode Switch Overdrive Pacing (PMOP)
I'd like to learn more about the EnTrust Dual Chamber ICD.
** When episodes with rate and duration overrides
are excluded.
References
- Medtronic EnTrust™ ICD Reference Manual.
- Medtronic EnTrust Implant Manual.
- Wathen MS, DeGroot PJ, Sweeney MO et al., for the
PainFREE Rx II Investigators. Prospective randomized multicenter trial
of empirical antitachycardia pacing versus shocks for spontaneous rapid
ventricular tachycardia in patients with implantable cardioverter-defibrillators:
pacing fast ventricular tachycardia reduces shock therapies (PainFREE
Rx II) trial results. Circulation. Oct 2004; 110: 2591 - 2596.
- Klein GK, Manolis A,, Viskin S , et al. Clinical
performance of Waveletú Dynamic VT/SVT Discrimination Algorithm
in a worldwide single chamber ICD population. Circulation.
Abstract #1650, Oct 2004; Vol. 110, No. 17.
- Medtronic Human Factors Report, 2003, data
on file.
- ICD Discrimination from supraventricular tachycardia by a Wavelet-transform based morphology algorithm; Europace 1 (suppl): D33, July 2000.
- Swerdlow CD, Brown ML, Lurie K, et al. Discrimination of ventricular tachycardia from supraventricular tachycardia by a downloaded wavelet-transform algorithm: a paradigm for development of implantable cardioverter defibrillator detection algorithms. J Cardiovasc Electrophysiol. May 2002;13(5):432-441.PMID: 12030523.
|